troglitazone has been researched along with alitretinoin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, S; Fang, S; Kim, DK; Kim, I; Krishnaiah, M; Kwon, Y; Lee, HJ; Lee, Y; Oh, AR; Park, J; Park, S; Sankham, MR; Shim, S; Shin, I; Vu, TNL | 1 |
| Asou, H; Elstner, E; Kamada, N; Koeffler, HP; Kubota, T; Verbeek, W; Williamson, E | 1 |
| Canas, X; Irie, Y; Kimura, K; Nagase, I; Saito, M; Yoshida, S; Yoshida, T | 1 |
| Huang, H; Jazayeri, A; Kuparadze, K; Nau, H; O'Brien, WF; Porter, GW; Porter, KB; Spellacy, WN; Tsibris, JC; Tzimas, G | 1 |
| Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH | 1 |
| Ahn, YH; Cha, JY; Kim, HI; Kim, JW; Kim, KS; Kim, SH | 1 |
| Kitamura, S; Kiyohara, T; Matsuzawa, Y; Miyazaki, Y; Nagasawa, Y; Shinomura, Y; Toyota, M | 1 |
| Breyer, B; Cheng, H; Feng, T; Haydon, RC; He, TC; Ishikawa, A; Jiang, W; Montag, A; Peabody, T; Simon, MA; Zhou, L | 1 |
| Dono, K; Hayashi, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Takahashi, Y; Tsujie, M; Umeshita, K | 1 |
| Aoun, P; Simpkins, JW; Watson, DG | 1 |
| Dono, K; Hayashi, N; Hiraoka, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Tsujie, M; Umeshita, K | 1 |
| Hashimoto, Y; Imamura, M; Itami, A; Ito, T; Kaganoi, J; Kawabe, A; Kawamura, J; Maeda, M; Shimada, Y; Watanabe, G | 1 |
| Arai, H; Chun, TH; Doi, K; Fukunaga, Y; Inoue, M; Itoh, H; Masatsugu, K; Nakao, K; Saito, T; Sakaguchi, S; Sawada, N; Tanaka, T; Yamashita, J | 1 |
| Buechler, C; Kirchner, S; Laberer, S; Neumeier, M; Schäffler, A; Schölmerich, J; Weigert, J; Weiss, T | 1 |
| Al-Makdissy, N; Becuwe, P; Chedotal, A; Collet, P; Dauça, M; Devignes, MD; Domenjoud, L; Donner, M; Huin-Schohn, C; Kerjan, G; Murad, H; Schohn, H | 1 |
| Dansette, PM; Johnson, EF; Sansen, S; Schoch, GA; Stout, CD; Yano, JK | 1 |
| Beckmann, MW; Faschingbauer, F; Goecke, TW; Henke, C; Langbein, M; Ruebner, M; Schild, RL; Schmidt, D; Strick, R; Strissel, PL | 1 |
| Cui, T; Liu, L; Liu, Y; Mou, J; Pei, DS; Zhang, SN; Zhu, ZA | 1 |
| Gambill, J; Hanson, AM; Kelley, MD; Phomakay, V; Staten, CT | 1 |
20 other study(ies) available for troglitazone and alitretinoin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of (
Topics: Acrylates; Animals; Bile Acids and Salts; Esters; Intestines; Liver; Mice; Non-alcoholic Fatty Liver Disease; Rats; Receptors, Cytoplasmic and Nuclear | 2022 |
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
Topics: Alitretinoin; Antineoplastic Agents; Antioxidants; Cell Cycle; Cell Differentiation; Cell Division; Chromans; DNA-Binding Proteins; HL-60 Cells; Humans; Leukemia, Myeloid; Receptors, Cytoplasmic and Nuclear; Superoxides; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured; U937 Cells | 1999 |
Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
Topics: Alitretinoin; Animals; Carrier Proteins; Cells, Cultured; Chromans; Dimerization; Drug Synergism; Epoprostenol; Gene Expression Regulation; Ion Channels; Mitochondrial Proteins; Muscle, Skeletal; Oleic Acid; Palmitates; Protein Isoforms; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Triiodothyronine; Troglitazone; Uncoupling Protein 3 | 1999 |
Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
Topics: Alitretinoin; Animals; Carcinogens; Chromans; Drug Implants; Estradiol; Female; Guinea Pigs; Humans; Leiomyomatosis; Menstrual Cycle; Myometrium; Neoplasm Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Uterine Neoplasms | 1999 |
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 1999 |
Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Topics: Alitretinoin; Animals; Base Sequence; Cell Line; Cells, Cultured; Chromans; Consensus Sequence; Dimerization; DNA-Binding Proteins; Gene Expression Regulation; Glucose Transporter Type 2; Hypoglycemic Agents; Islets of Langerhans; Male; Monosaccharide Transport Proteins; Promoter Regions, Genetic; Protein Multimerization; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Recombinant Proteins; Retinoid X Receptors; Sequence Alignment; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Troglitazone | 2000 |
Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Carcinoma; Cell Division; Chromans; Cyclin D1; Dose-Response Relationship, Drug; Drug Synergism; G1 Phase; Humans; Pancreatic Neoplasms; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2002 |
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Division; Chromans; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Osteosarcoma; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Neoplasm; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2002 |
Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Topics: Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Cell Division; Chromans; Cyclin D1; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Nuclear Proteins; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Topics: Alitretinoin; Animals; Cell Line; Cell Survival; Chromans; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Humans; Hydrogen Peroxide; Mice; Neuroprotective Agents; Oxidation-Reduction; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin; Troglitazone | 2003 |
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Topics: Adenocarcinoma; Alitretinoin; Antineoplastic Agents; Apoptosis; Biliary Tract Neoplasms; Cell Differentiation; Cell Division; Chromans; Drug Screening Assays, Antitumor; Drug Synergism; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Topics: Alitretinoin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Caspases; Cell Division; Chromans; Drug Evaluation; Esophageal Neoplasms; Humans; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Topics: Alitretinoin; Angioplasty, Balloon; Animals; Aorta; Arteriosclerosis; Binding, Competitive; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CCL2; Chromans; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Expression Regulation; Humans; Macrophages; Male; Monocytes; Pioglitazone; PPAR gamma; Prostaglandin D2; Rabbits; Receptors, CCR2; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Time Factors; Tretinoin; Troglitazone; Vascular Endothelial Growth Factor A; Wound Healing | 2005 |
Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.
Topics: Adiponectin; Alitretinoin; Animals; Caco-2 Cells; Cell Line; CHO Cells; Chromans; Cricetinae; DNA-Binding Proteins; Fenofibrate; HeLa Cells; Hepatocytes; Humans; Hydroxycholesterols; Liver X Receptors; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptors; Pioglitazone; PPAR alpha; Receptors, Adiponectin; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors; Thiazolidinediones; Tretinoin; Troglitazone; Up-Regulation | 2005 |
Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
Topics: Alitretinoin; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chromans; Dimerization; Fenofibrate; Gene Expression; HT29 Cells; Humans; K562 Cells; PPAR alpha; PPAR gamma; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Semaphorins; Thiazoles; Thiazolidinediones; Tretinoin; Troglitazone | 2006 |
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.
Topics: Acetates; Alitretinoin; Aryl Hydrocarbon Hydroxylases; Binding Sites; Chromans; Crystallography, X-Ray; Cyclopropanes; Cytochrome P-450 CYP2C8; Felodipine; Heme; Humans; Iron; Leukotriene Antagonists; Ligands; Molecular Conformation; Protein Binding; Quinolines; Substrate Specificity; Sulfides; Thiazolidinediones; Tretinoin; Troglitazone | 2008 |
Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
Topics: Alitretinoin; Cell Fusion; Cell Line; Chromans; Cyclic AMP-Dependent Protein Kinases; Endogenous Retroviruses; Female; Fetal Growth Retardation; Gene Expression Regulation; Gene Products, env; HELLP Syndrome; Humans; Mitogen-Activated Protein Kinase 14; Placenta; Placentation; PPAR gamma; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Response Elements; Retinoid X Receptor alpha; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiazolidinediones; Tretinoin; Troglitazone; Trophoblasts | 2012 |
Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Chromans; Down-Regulation; Humans; Hypoglycemic Agents; Intercalating Agents; PPAR gamma; Propidium; Proto-Oncogene Proteins c-bcl-2; Retinoid X Receptors; Stomach Neoplasms; Thiazolidinediones; Tretinoin; Troglitazone; Up-Regulation | 2013 |
9-cis-retinoic Acid and troglitazone impacts cellular adhesion, proliferation, and integrin expression in K562 cells.
Topics: Alitretinoin; Biological Availability; Cell Adhesion; Cell Proliferation; Chromans; Extracellular Matrix Proteins; Fibronectins; Humans; Integrin alpha5; K562 Cells; Oligopeptides; Thiazolidinediones; Time Factors; Tretinoin; Troglitazone; Vitronectin | 2014 |